Your browser doesn't support javascript.
loading
Towards tuberculosis elimination: an action framework for low-incidence countries.
Lönnroth, Knut; Migliori, Giovanni Battista; Abubakar, Ibrahim; D'Ambrosio, Lia; de Vries, Gerard; Diel, Roland; Douglas, Paul; Falzon, Dennis; Gaudreau, Marc-Andre; Goletti, Delia; González Ochoa, Edilberto R; LoBue, Philip; Matteelli, Alberto; Njoo, Howard; Solovic, Ivan; Story, Alistair; Tayeb, Tamara; van der Werf, Marieke J; Weil, Diana; Zellweger, Jean-Pierre; Abdel Aziz, Mohamed; Al Lawati, Mohamed R M; Aliberti, Stefano; Arrazola de Oñate, Wouter; Barreira, Draurio; Bhatia, Vineet; Blasi, Francesco; Bloom, Amy; Bruchfeld, Judith; Castelli, Francesco; Centis, Rosella; Chemtob, Daniel; Cirillo, Daniela M; Colorado, Alberto; Dadu, Andrei; Dahle, Ulf R; De Paoli, Laura; Dias, Hannah M; Duarte, Raquel; Fattorini, Lanfranco; Gaga, Mina; Getahun, Haileyesus; Glaziou, Philippe; Goguadze, Lasha; Del Granado, Mirtha; Haas, Walter; Järvinen, Asko; Kwon, Geun-Yong; Mosca, Davide; Nahid, Payam.
Affiliation
  • Lönnroth K; Global TB Programme, World Health Organization, Geneva, Switzerland Both authors contributed equally.
  • Migliori GB; WHO Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione S. Maugeri, IRCCS, Tradate, Italy Both authors contributed equally.
  • Abubakar I; TB Section, University College London and Public Health England, London, UK.
  • D'Ambrosio L; WHO Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione S. Maugeri, IRCCS, Tradate, Italy.
  • de Vries G; KNCV Tuberculosis Foundation, The Hague, The Netherlands.
  • Diel R; University Hospital Schleswig Holstein, Institute for Epidemiology, Kiel, Germany.
  • Douglas P; Global Health Borders Refugee and Onshore Services, Dept of Immigration and Border Protection, Sydney, Australia.
  • Falzon D; Global TB Programme, World Health Organization, Geneva, Switzerland.
  • Gaudreau MA; Centre for Communicable Diseases and Infection Control, Public Health Agency of Canada, Montreal, QC, Canada.
  • Goletti D; National Institute for Infectious Diseases, Rome, Italy.
  • González Ochoa ER; Research and Surveillance Group on TB, Leprosy and ARI, Epidemiology Board, Institute of Tropical Medicine "Pedro Kourí", Havana, Cuba.
  • LoBue P; Division of TB Elimination, Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Matteelli A; Global TB Programme, World Health Organization, Geneva, Switzerland.
  • Njoo H; Centre for Communicable Diseases and Infection Control, Public Health Agency of Canada, Montreal, QC, Canada.
  • Solovic I; TB Dept, National Institute for TB, Respiratory Diseases and Thoracic Surgery, Vysne Hagy, Catholic University, Ruzomberok, Slovakia.
  • Story A; Find and Treat, London, UK.
  • Tayeb T; National TB Control Programme, Ministry of Health, Riyadh, Saudi Arabia.
  • van der Werf MJ; European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden.
  • Weil D; Global TB Programme, World Health Organization, Geneva, Switzerland.
  • Zellweger JP; Swiss Lung Association, Bern, Switzerland.
  • Abdel Aziz M; WHO Regional Office for the Eastern Mediterranean, Cairo, Egypt.
  • Al Lawati MR; Ministry of Health, Muscat, Oman.
  • Aliberti S; Università degli Studi di Milano - Bicocca, UO Clinica Pneumologica, AO San Gerardo, Monza, Italy.
  • Arrazola de Oñate W; Belgian Lung and Tuberculosis Association, Brussels, Belgium.
  • Barreira D; Ministry of Health, Brasilia, Brazil.
  • Bhatia V; Global TB Programme, World Health Organization, Geneva, Switzerland.
  • Blasi F; Dipartimento Fisiopatologia Medico-Chirurgica e dei Trapianti, University of Milan, IRCCS Fondazione Cà Granda, Milan, Italy.
  • Bloom A; US Agency for International Development, Washington, DC, USA.
  • Bruchfeld J; Unit of Infectious Diseases, Institution of Medicine, Karolinska Institute Solna and Karolinska University Hospital, Stockholm, Sweden.
  • Castelli F; University of Brescia, Brescia, Italy.
  • Centis R; WHO Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione S. Maugeri, IRCCS, Tradate, Italy.
  • Chemtob D; Ministry of Health, Jerusalem, Israel.
  • Cirillo DM; IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Colorado A; Advocates for Health International, San Diego, CA, USA.
  • Dadu A; TB and M/XDR-TB Control Programme, WHO Regional Office for Europe, Copenhagen, Denmark.
  • Dahle UR; Norwegian Institute of Public Health, Oslo, Norway.
  • De Paoli L; Médecins sans Frontières, Rome, Italy.
  • Dias HM; Global TB Programme, World Health Organization, Geneva, Switzerland.
  • Duarte R; General Directorate of Health, Lisbon, Portugal.
  • Fattorini L; Istituto Superiore di Sanita, Rome, Italy.
  • Gaga M; National Referral Centre for Mycobacteria, Athens Chest Hospital, Ministry of Health, Athens, Greece.
  • Getahun H; Global TB Programme, World Health Organization, Geneva, Switzerland.
  • Glaziou P; Global TB Programme, World Health Organization, Geneva, Switzerland.
  • Goguadze L; International Federation of Red Cross and Red Crescent Societies, Geneva, Switzerland.
  • Del Granado M; WHO Regional Office for the Americas, Washington, DC, USA.
  • Haas W; Dept of Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany.
  • Järvinen A; Finnish Lung Health Association, Helsinki, Finland Helsinki University Central Hospital, Division of Infectious Diseases, Helsinki, Finland.
  • Kwon GY; Korea Centers for Disease Control and Prevention (KCDC), Ministry of Health and Welfare, Seoul, Republic of Korea.
  • Mosca D; International Organization for Migration, Geneva, Switzerland.
  • Nahid P; University of California, San Francisco, CA, USA American Thoracic Society (ATS), New York, NY, USA.
Eur Respir J ; 45(4): 928-52, 2015 Apr.
Article in En | MEDLINE | ID: mdl-25792630
ABSTRACT
This paper describes an action framework for countries with low tuberculosis (TB) incidence (<100 TB cases per million population) that are striving for TB elimination. The framework sets out priority interventions required for these countries to progress first towards "pre-elimination" (<10 cases per million) and eventually the elimination of TB as a public health problem (less than one case per million). TB epidemiology in most low-incidence countries is characterised by a low rate of transmission in the general population, occasional outbreaks, a majority of TB cases generated from progression of latent TB infection (LTBI) rather than local transmission, concentration to certain vulnerable and hard-to-reach risk groups, and challenges posed by cross-border migration. Common health system challenges are that political commitment, funding, clinical expertise and general awareness of TB diminishes as TB incidence falls. The framework presents a tailored response to these challenges, grouped into eight priority action areas 1) ensure political commitment, funding and stewardship for planning and essential services; 2) address the most vulnerable and hard-to-reach groups; 3) address special needs of migrants and cross-border issues; 4) undertake screening for active TB and LTBI in TB contacts and selected high-risk groups, and provide appropriate treatment; 5) optimise the prevention and care of drug-resistant TB; 6) ensure continued surveillance, programme monitoring and evaluation and case-based data management; 7) invest in research and new tools; and 8) support global TB prevention, care and control. The overall approach needs to be multisectorial, focusing on equitable access to high-quality diagnosis and care, and on addressing the social determinants of TB. Because of increasing globalisation and population mobility, the response needs to have both national and global dimensions.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tuberculosis / Developed Countries / Communicable Disease Control / Global Health / Antitubercular Agents Type of study: Incidence_studies / Prognostic_studies / Risk_factors_studies Aspects: Determinantes_sociais_saude Limits: Female / Humans / Male Language: En Journal: Eur Respir J Year: 2015 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tuberculosis / Developed Countries / Communicable Disease Control / Global Health / Antitubercular Agents Type of study: Incidence_studies / Prognostic_studies / Risk_factors_studies Aspects: Determinantes_sociais_saude Limits: Female / Humans / Male Language: En Journal: Eur Respir J Year: 2015 Document type: Article